Companies selling genetic testing products tout the benefits of DNA-based insights learning more about health, lineage, family tree so that consumers can seek medical attention, customize their diet or exercise regimen, find long-lost relatives, or understand more about their background. But for consumers to realize benefits from DNA-based products or services, consumers need to be able to trust their accuracy and trust that the companys practices related to the DNA of privacy (data minimization, purpose limitations, retention limits, etc.) will protect the privacy of their DNA. Here are some lessons on privacy, data security, truth in advertising, and artificial intelligence (AI) drawn from a trio of FTC enforcement actions involving sellers of genetic testing products: CRI Genetics, 1Health/Vitagene, and Genelink.
Protecting biometric information including genetic data is a top FTC priority. Since announcing itsBiometric Policy Statementin May 2023, the FTC has settled actions against two sellers of direct-to-consumer DNA testing kits. Why are these cases so important? Genetic data reveals sensitive information not only about consumers health, characteristics, and ancestry, but also about their families. While some other data types can be stripped of identifying characteristics, thats not necessarily the case when it comes to genetic information. Where the sensitivity of the data is high, so too is the risk of harm, particularly in this era of increasing biometric surveillance. The FTCs actions in Amazon/Alexa and Ring to protect voice recordings and videos further illustrate this point. To stay on the right side of the law, heed the lessons from these cases.
Secure genetic data. In both 1Health/Vitagene (consumers may know the company as Vitagene) and Genelink, the FTC charged that sellers of genetic-based products had subpar data security. The FTCs Vitagene complaint alleges that the company didnt inventory its genetic data, so it wasnt even aware that it had stored some of it in a cloud storage bucket accessible to the public. In addition, the company allegedly didnt use access controls, didnt encrypt that publicly accessible data, didnt log or monitor access to it, and didnt remedy the problem even after receiving credible warnings. Genelink preceded Vitagene by about nine years and yet there are eerie similarities. According to the Genelink complaint,the company maintained sensitive data in clear text, failed to limit employee and contractor access to sensitive data, failed to assess the risks to that data, and didnt include terms in the contract to require contractors to use safeguards and to allow Genelink to oversee their practices. The data practices described in both complaints are shoddy for any data, but especially for sensitive genetic information, where the risk of harm to consumers from exposure of that data is high. If you collect or store genetic data, youre on notice that the FTC expects security in line with the sensitivity of the data.
Secure customer accounts. Securing genetic data doesnt just mean good network security (although thats a must). It also means securing customer accounts through which a bad actor could access genetic data or other personal information. The more sensitive the data, the more valuable it may be to bad actors which means customer accounts are likely targets for hackers. The Ring matter illustrates that point. According to the complaint, the home security camera company failed to take reasonable steps to secure customer accounts against common hacking techniques, including credential-stuffing attacks. (Credential stuffing involves the use of credentials, such as usernames and passwords, obtained from one breached account to gain access to a consumers other accounts.) The complaint alleges that Ring only used half-measures to prevent these attacks. For example, Ring made multi-factor authentication available to consumers, but didnt require them to use it even though customer accounts were the gateway to highly sensitive information like stored videos and live streams of consumers in private spaces of their homes. If your customer accounts offer data thieves a similar gateway to sensitive data (for example, results from genetic testing), learn from the Ring case and properly secure those accounts.
Dont oversell: Can you support your accuracy claims about genetic testing? Be careful not to exaggerate your claims about your genetic testing product. Theres a line between puffery and deception that you dont want to cross. According to the CRI Genetics complaint, the company among other things overstated the accuracy of their test results (accuracy greater than 99.9%) and falsified reviews. Heres the truth about DNA testing for ancestry: Companies estimate consumers ancestry by comparing consumers DNA with the companies proprietary DNA reference data. Their algorithms predict consumers ancestry, with varying margins of error. DNA testing for ancestry is, therefore at best an estimation of ancestry, not a precise science. The Genelink complaint alleges that the company claimed their genetically customized nutritional supplements could treat diabetes, heart disease, arthritis, insomnia, and other health conditions all without scientific support. When making claims about the accuracy of genetic testing or the purported benefits of DNA-related products, stick with reliable science. If you dont have a reasonable basis to support your claim, dont make it in the first place.
The FTC is watching how companies use and claim to use Artificial Intelligence. DNA algorithms are no exception. Its no secret that the FTC is focused on making sure that consumers can enjoy the benefits of AI without suffering substantial harms like bias, privacy invasions (Amazon/Alexa and Ring), or questionable accuracy (WealthPress, DK Automation, Automators AI). That holds true when it comes to DNA algorithms. In the CRI Genetics matter, the FTC alleged that the patented DNA algorithm the company touted in its ads was not in fact patented and didnt generate the highly accurate results the company claimed. In this age of AI, some companies may be tempted to use loose talk about AI and algorithms, perhaps as a means of conveying technological sophistication. Watch out. If youre promoting your AI or algorithm, make sure your claims dont deceive or otherwise harm consumers.
The FTC has a strong track record of challenging deceptive or unfair dark patterns, including when it comes to obtaining consent for the use and disclosure of genetic data. Recent enforcement actions like Amazon/Prime, Publishers Clearinghouse, and Vonage demonstrate the high priority the FTC places on challenging allegedly illegal dark patterns manipulative designs that coerce consumers into decisions they wouldnt knowingly agree to make. The CRI Genetics matter reinforces this point. According to the complaint, the company used dark patterns confusing pop-ups and directions, bogus rewards, claimed urgency to push consumers into buying more. In the ongoing battle against illegal dark patterns, the orders in both CRI Genetics and Vitagene require the companies to obtain affirmative express consent consent that precludes the use of dark patterns for future uses or disclosures of genetic data. Companies are on notice that they shouldnt be using dark patterns to get consent.
Dont commit a foul when changing the rules of the game. The Vitagene order includes that affirmative express consent requirement because the company had allegedly changed its terms on a key issue but the company didnt get real consent from consumers for this material retroactive change. According to the complaint, changing the rules of the game in the privacy policy was unfair, even though the company hadnt yet implemented the change. The bottom line is that consumers should know what to expect from your data practices. A bait-and-switch approach to collecting personal information (especially genetic data) doesnt fit with the FTC Acts requirements.
Nothing but the truth. According to the FTCs complaint in Vitagene, the company made detailed privacy promises for example, about how it stored genetic data and destroyed genetic samples but didnt deliver on those promises. The company made these promises prominently (a good thing!), including on a page dedicated to genetic privacy. But, according to the complaint, rather than storing genetic data without identifying information, it stored results with names and other personal information. When the time came to delete genetic data, the company couldnt delete it because they didnt even know where some of it was stored meaning that they broke that promise, too. And the company failed to have a process in place through contractual obligations, in particular to ensure that third-party labs destroyed genetic samples after testing. The upshot: If youre selling genetic testing products (or any product, for that matter), you owe consumers nothing less than the truth.
The consequences for ignoring these warnings can be significant. In both recent genetic testing matters, the companies ended up paying substantial financial settlements, either as civil penalties under California state law (CRI Genetics) or for consumers redress (Vitagene). Furthermore, the orders in both cases required the companies to delete or destroy certain valuable biometric data or materials. These remedies were on top of other order provisions, such as prohibitions on misrepresentations, required notice to consumers of the FTCs action, mandates to obtain affirmative express consent for the future use or disclosure of genetic data, and a mandated security program with independent assessments. Its clear that the consequences of non-compliance with the FTC Act and other laws can be significant. Your best bet is to stay on the right side of the law by following these lessons.
Continue reading here:
The DNA of privacy and the privacy of DNA - Federal Trade Commission News
- Sequence errors are canaries in a coal mine in genetics studies, sleuth says - Retraction Watch - March 30th, 2025 [March 30th, 2025]
- Significance of noninvasive prenatal testing using massively parallel sequencing in women with twin or vanishing twin pregnancies | Journal of Human... - March 30th, 2025 [March 30th, 2025]
- All You Need to Know About Atossa Genetics (ATOS) Rating Upgrade to Buy - Yahoo Finance - March 30th, 2025 [March 30th, 2025]
- 23andMe Stock Is Surging After a Bankruptcy Judge Cleared Genetics Business Sale. Heres Why You Need to Stay Far Away From ME Shares. - Barchart - March 30th, 2025 [March 30th, 2025]
- Dairy producers leverage genetics to optimize milk composition for processing - Feedstuffs - March 30th, 2025 [March 30th, 2025]
- Several Insiders Invested In Opus Genetics Flagging Positive News - Yahoo Finance - March 30th, 2025 [March 30th, 2025]
- Human genetics and biotechnology company 23andMe to pursue bankruptcy sale after failed prepetition attempt Case Profile - ION Analytics - March 30th, 2025 [March 30th, 2025]
- AP Biology Students At NLHS Explore Genetics With Build-A-Baby Monster Lab - EastTexasRadio.com - March 30th, 2025 [March 30th, 2025]
- Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks - Yahoo Finance - March 15th, 2025 [March 15th, 2025]
- Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward - PR Newswire - March 15th, 2025 [March 15th, 2025]
- S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer - Medscape - March 15th, 2025 [March 15th, 2025]
- Fowl Play: How Chicken Genetics Barons Created the Egg Crisis - The Big Newsletter - March 15th, 2025 [March 15th, 2025]
- Exposure to violence alters human genetics for future generations - Earth.com - March 5th, 2025 [March 5th, 2025]
- Family-based genetics identifies association of CUBN IL1RL1 and PRKN variants with leprosy in Bangladesh - Nature.com - March 5th, 2025 [March 5th, 2025]
- The role of genetics in infant hearing loss: What parents need to know - The Times of India - March 5th, 2025 [March 5th, 2025]
- Analyzing Genetics May Lead to Better Contraceptive Experiences for Women - Yale School of Medicine - March 5th, 2025 [March 5th, 2025]
- Fulgent Genetics Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance - March 5th, 2025 [March 5th, 2025]
- Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the... - February 25th, 2025 [February 25th, 2025]
- Dual recombinase-mediated intersectional genetics defines the functional heterogeneity of neural stem cells in adult hippocampus - Nature.com - February 25th, 2025 [February 25th, 2025]
- Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio - Yahoo Finance - February 25th, 2025 [February 25th, 2025]
- The Genetics of Creativity: Can Creative Talent Be Inherited? - Etownian - February 25th, 2025 [February 25th, 2025]
- Weight and metabolism determined more by genetics than diet - WVTF - February 25th, 2025 [February 25th, 2025]
- Beyond genetics: The biggest factors that influence health and aging - Earth.com - February 25th, 2025 [February 25th, 2025]
- Study finds lifestyle, environment have greater impact on lifespan than genetics - CBS Boston - February 25th, 2025 [February 25th, 2025]
- 6 Things to Know About Genetics in GI Cancers - Gastroenterology & Endoscopy News - February 25th, 2025 [February 25th, 2025]
- Virologist Wendy Barclay: Wild avian viruses are mixing up their genetics all the time. Its like viral sex on steroids - The Guardian - February 3rd, 2025 [February 3rd, 2025]
- Do you find coffee too bitter? Scientists explain how your genetics and roasting process affect the flavour - Hindustan Times - February 3rd, 2025 [February 3rd, 2025]
- 2025 Illinois Performance Tested Bull Sale prioritizes trusted genetics for herd growth - Morning Ag Clips - - February 3rd, 2025 [February 3rd, 2025]
- Game-Changing Cancer Detection Tool Spots What Others Miss: New Breakthrough from SOPHiA GENETICS - StockTitan - February 3rd, 2025 [February 3rd, 2025]
- Integrative genetics and multiomics analysis reveal mechanisms and therapeutic targets in vitiligo highlighting JAK STAT pathway regulation of CTSS -... - January 23rd, 2025 [January 23rd, 2025]
- deCODE genetics: Complete recombination map of the human-genome, a major step in genetics - Financial Times - January 23rd, 2025 [January 23rd, 2025]
- Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology - Yahoo Finance - January 23rd, 2025 [January 23rd, 2025]
- Bjarni V. Halldorsson and Kari Stefansson, scientists at deCODE genetics, discuss the paper: Complete recombination map of the human-genome, published... - January 23rd, 2025 [January 23rd, 2025]
- Myriad Genetics Doubles Cancer Testing Rates with Revolutionary Online Screening Tool - StockTitan - January 23rd, 2025 [January 23rd, 2025]
- Genetics, brain development, and mental health shape teen eating - News-Medical.Net - January 15th, 2025 [January 15th, 2025]
- Building Better Flu Shots Based on Antibody Responses and Genetics - Vax-Before-Travel - January 15th, 2025 [January 15th, 2025]
- Its in the Genes: Weight and Metabolism Determined by Genetics More Than Diet - Cville Right Now - January 15th, 2025 [January 15th, 2025]
- It's in the genes: Weight and metabolism determined by genetics more than diet - Medical Xpress - January 15th, 2025 [January 15th, 2025]
- Trump and Musk are obsessed with genetics but theres no science behind their simplistic views - The Guardian - January 1st, 2025 [January 1st, 2025]
- From Stonehenge's origins to ice age baby genetics how well did you follow this year's top archaeology stories? - Livescience.com - January 1st, 2025 [January 1st, 2025]
- William Thilly, MIT genetics professor who invented Apple Jacks cereal, dies at 79 - The Boston Globe - January 1st, 2025 [January 1st, 2025]
- Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- Using the PERC Database to Gather Insights on Epilepsy Genetics: Julie Ziobro, MD, PhD; John Schreiber, MD - Neurology Live - December 23rd, 2024 [December 23rd, 2024]
- Myriad Genetics' Breakthrough Cancer Test Named Top 10 Genomic Advance by Leading Journal - StockTitan - December 23rd, 2024 [December 23rd, 2024]
- Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-roll Line for the Holidays - Yahoo Finance - December 23rd, 2024 [December 23rd, 2024]
- Surprising yields, impressive genetics and an early harvest in 2024 Ohio Ag Net - Ohio's Country Journal and Ohio Ag Net - December 9th, 2024 [December 9th, 2024]
- Using music to help people with dementia; supporting breastfeeding radiologists; genetics and Type 2 diabetes; plus other news stories with VUMC... - December 9th, 2024 [December 9th, 2024]
- Genetics and suicideWhats the link? - Genetic Literacy Project - December 9th, 2024 [December 9th, 2024]
- Genetics is all fun and games for a Rochester card game creator - Rochester Post Bulletin - November 28th, 2024 [November 28th, 2024]
- Community engagement conduct for genetics and genomics research: a qualitative study of the experiences and perspectives of key stakeholders in Uganda... - November 28th, 2024 [November 28th, 2024]
- Dietary restriction interventions: lifespan benefits need resilience and are limited by immune compromise and genetics - Nature.com - November 28th, 2024 [November 28th, 2024]
- Texas A&M Researchers Uncover Secrets Of Horse Genetics For Conservation, Breeding - Texas A&M University Today - November 20th, 2024 [November 20th, 2024]
- Myriad Genetics Announces Prequel Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy - GlobeNewswire - November 20th, 2024 [November 20th, 2024]
- Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance - November 20th, 2024 [November 20th, 2024]
- Precision mutational scanning: your multipass to the future of genetics - Nature.com - November 20th, 2024 [November 20th, 2024]
- Advancements of Haploid Technology in Crops: New Horizons in Breeding and Genetics - Frontiers - November 20th, 2024 [November 20th, 2024]
- Toward advances in retinoblastoma genetics in Kenya - Nature.com - November 12th, 2024 [November 12th, 2024]
- CRISPR/Cas9 screens identify key host factors that enhance rotavirus reverse genetics efficacy and vaccine production - Nature.com - November 12th, 2024 [November 12th, 2024]
- Genetics Play Key Role in Animal Health and Welfare, Aggression and Handling - Farms.com - November 12th, 2024 [November 12th, 2024]
- Episode 174: Rudy Tanzi talks about genetics, aging and the hallmarks of Alzheimers - IHMC - October 26th, 2024 [October 26th, 2024]
- Ocuphire and Opus Genetics merge to develop IRD gene therapy - Pharmaceutical Technology - October 26th, 2024 [October 26th, 2024]
- The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics - PR Newswire - October 26th, 2024 [October 26th, 2024]
- The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics - WV News - October 26th, 2024 [October 26th, 2024]
- Faculty of Science | Protecting Canadas number one crop through genetics - UM Today - October 26th, 2024 [October 26th, 2024]
- Ocuphire and Opus Genetics merge to develop IRD gene therapy - Yahoo Finance - October 26th, 2024 [October 26th, 2024]
- Opinion | Fascinated by genetics? Where are the peas Trump made to fornicate? - The Washington Post - October 13th, 2024 [October 13th, 2024]
- Dietary restriction can extend lifespan but genetics matters more - Nature.com - October 13th, 2024 [October 13th, 2024]
- 'They have much stronger players' - Bangladesh assistant coach bizarrely blames 'genetics' for lack of six hitters in the team - Sporting News - October 13th, 2024 [October 13th, 2024]
- Medical Moment: Genetics and breast cancer with USA Health Genetic Counselor Cassie Gurganus - AOL - October 13th, 2024 [October 13th, 2024]
- Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer - Yahoo Finance - October 13th, 2024 [October 13th, 2024]
- An ideologically-based and misleading critique of how modern genetics is taught - Why Evolution Is True - October 13th, 2024 [October 13th, 2024]
- 2024 Mercedes-AMG C63 Review: Bold But Beholden to Its Genetics - Newsweek - October 2nd, 2024 [October 2nd, 2024]
- Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date - GlobeNewswire - October 2nd, 2024 [October 2nd, 2024]
- Digbi Health Launches an SEC-regulated Offering, Giving Millions the Opportunity to Invest in Groundbreaking Genetics and Gut Microbiome-based Care... - October 2nd, 2024 [October 2nd, 2024]
- The role of genetics in depression | Second Opinion - KCRW - September 23rd, 2024 [September 23rd, 2024]
- Tilapia genetics company Spring Genetics teams up with UK data firm to improve fish welfare - SeafoodSource - September 23rd, 2024 [September 23rd, 2024]
- Picky eating in kids is mostly due to genetics, study says - Motherly Inc. - September 23rd, 2024 [September 23rd, 2024]
- Research Shows That Fussy Eating In Children Is Mainly Influenced By Genetics - RTTNews - September 23rd, 2024 [September 23rd, 2024]
- Genetics colloquium: Chris Hittinger on the genomic making of metabolic niche breadth Sep. 11 - University of WisconsinMadison - September 15th, 2024 [September 15th, 2024]